US Broker Ratings

Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and 21.66% Potential Upside Attract Investors

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the medical device sector, particularly noted for its innovative solutions in musculoskeletal healthcare. As a U.S.-based company with a..

BioNTech SE (BNTX) Stock Analysis: Navigating Potential Upside of 32.74% Amidst Biotech Innovations

BioNTech SE (NASDAQ: BNTX) stands as a prominent player in the healthcare sector, specifically within the biotechnology industry. Based in Germany, the company has carved a niche in developing cutting-edge..

Repligen Corporation (RGEN) Stock Analysis: A Potential 39.91% Upside with Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in developing cutting-edge bioprocessing technologies and systems. With a market capitalization of $7.68 billion, Repligen is a significant..

Cencora, Inc. (COR) Stock Analysis: Exploring a 11.74% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, has recently undergone a significant rebranding, yet it continues to command attention in the healthcare sector as a formidable player in..

Exelixis, Inc. (EXEL) Investor Outlook: Navigating Potential Upside in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, stands at an intriguing juncture for investors. With a market capitalization of $11.78 billion, Exelixis is a significant entity..

The Cooper Companies, Inc. (COO) Stock Analysis: Discovering a 9.65% Upside Potential Amidst Robust Healthcare Innovations

The Cooper Companies, Inc. (NYSE: COO) has carved a niche in the healthcare industry, specifically within the medical instruments and supplies sector. With a solid market capitalization of $16.5 billion,..

Eli Lilly (LLY) Stock Analysis: A Healthcare Giant with a 15.54% Upside Potential

Eli Lilly and Company (NYSE: LLY) has established itself as a formidable player in the healthcare sector, particularly in the pharmaceutical industry. With a staggering market capitalization of $932.32 billion,..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 9.31% Potential Upside

Baxter International Inc. (NYSE: BAX) stands as a stalwart in the healthcare sector, offering a diverse portfolio of medical instruments and supplies. Headquartered in Deerfield, Illinois, and with a market..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Summit Therapeutics Inc. (SMMT) Stock Analysis: A Biotech Gem with a 119.78% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT) stands out in the competitive healthcare sector as a biotech company with a compelling growth narrative. Headquartered in Miami, Florida, Summit Therapeutics is making waves..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Growth with a 6.62% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, with a robust market capitalization of $14.94 billion. Headquartered in King of Prussia, Pennsylvania, UHS..

Royalty Pharma (RPRX): Unveiling a 12.86% Upside Potential with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) is a unique player in the biotechnology sector, offering investors exposure to a diversified portfolio of biopharmaceutical royalties. With a market capitalization of $26.14 billion,..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating Growth with 6.32% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, has been on the radar of savvy investors, particularly due to its innovative..

Stryker Corporation (SYK) Stock Analysis: Navigating a 15.94% Potential Upside in the Healthcare Sector

Stryker Corporation (NYSE: SYK) stands out in the healthcare sector, particularly in the medical devices industry, with a market capitalization of approximately $140.08 billion. Headquartered in Portage, Michigan, the company..

ICON plc (ICLR) Stock Analysis: Unveiling an 87.74% Potential Upside in Healthcare Diagnostics

ICON plc (ICLR), a prominent player in the global healthcare diagnostics and research industry, stands as a compelling opportunity for investors seeking growth in the healthcare sector. Headquartered in Dublin,..

Hologic, Inc. (HOLX) Stock Report: Unpacking the 2.08% Upside Potential for Investors

Hologic, Inc. (HOLX), a healthcare giant in the medical instruments and supplies industry, is capturing investor attention with its promising outlook and recent performance metrics. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 16% Potential Upside with Robust Revenue Growth

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a significant player in the healthcare sector, primarily operating within the medical devices industry. With a market capitalization of $36.61 billion, this..

DaVita Inc. (DVA) Stock Analysis: A Healthcare Giant with a Robust ROE and a Modest Upside

DaVita Inc. (DVA), a prominent player in the healthcare sector, particularly in the medical care facilities industry, offers a compelling investment narrative for those interested in the provision of kidney..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring an 8.08% Potential Upside with Strong Buy Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a key player in the biotechnology industry, continues to capture investor attention with its robust market presence and innovative product pipeline. Based in Tarrytown, New..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Prospects Amidst Strong Revenue Growth

Investors with a keen eye on the healthcare sector will find GSK plc (GSK) an intriguing entity in the pharmaceutical landscape. Headquartered in London, United Kingdom, this healthcare titan boasts..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds